Cytotherapeutics, Inc.

Neurotech S.a.

Mark D Lindner

Joseph P Hammang

Frank T Gentile

Shelley R Winn

Dwaine F Emerich

Edward E Baetge

This invention provides improved devices and methods for long-term, stable expression of a biologically active molecule using a biocompatible capsule containing genetically engineered cells for the effective delivery of biologically active molecules to effect or enhance a biological function within a mammalian host. The novel capsules of this invention are biocompatible and are easily retrievable. This invention specifically provides improved methods and compositions which utilize cells transfected with recombinant DNA molecules comprising DNA sequences coding for biologically active molecules operatively linked to promoters that are not subject to down regulation in vivo upon implantation into a mammalian host. Furthermore, the methods of this invention allow for the long-term, stable and efficacious delivery of biologically active molecules from living cells to specific sites within a given mammal. In addition, this invention provides a general means for maintaining, for extended periods of time, the in vivo expression of transgenes.

Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules

Compositions and methods for the delivery of biologically active

Delivery of biologically active molecules using cells contained in

Growing community of inventors

Bristol, RI, United States of America

Mark D Lindner